Selfdiagnostics is an Estonian-German certified research and development company that was established in 2008. They are engaged in the development, production, and sale of medical devices. With a focus on both professional and home use, their product portfolio includes a wide range of medical devices such as diagnostic tests, inhalers, and blood pressure monitors. As one of the largest sellers of HIV home tests in Germany and with a significant market share in rapid tests and inhalers in Estonia, Selfdiagnostics serves a diverse range of customers including pharmacy chains, government agencies, and medical institutions in Estonia, Germany, and other countries.

In response to the outbreak of the Covid-19 pandemic, Selfdiagnostics has refocused its operations and now specializes in the development of key RNA diagnostic products for SARS-CoV-2 and other respiratory viruses. They have developed their own technology and hold several patents in the field. Selfdiagnostics also offers direct-to-consumer sales channels through their websites for both international customers (www. selfdiagnostics.

com) and Estonian customers (www. tervisetestid. ee). The company is led by a highly experienced team, including the co-founder and CEO Marko Lehes, who has over 20 years of executive experience in the healthcare industry, and Dr.

Katrin Krõlov, the Head of R&D, who has more than 15 years of scientific research and team management experience. With a commitment to innovation and high-quality medical devices, Selfdiagnostics is dedicated to improving healthcare outcomes and providing reliable solutions for medical professionals and individuals alike.